MARATTO

article · Records of Pharmaceutical and Biomedical Sciences/Records of Pharmaceutical & Biomedical Sciences

Chemodiversity of the genus Chaetomium Secondary Metabolites

2024Open accessSuez Canal University

Abstract

Since Alexander Fleming discovered penicillin in 1982 fungi was used as a very important source of antibiotics and secondary metabolites due to their importance. Similar to higher plants and bacteria, fungi have the capacity to generate various secondary metabolites having biological effects, such as alkaloids, terpenoids and anthraquinones. The Ascomycete genus Chaetomium is a rich source of new and bioactive secondary metabolites, which are crucial compounds. A broad variety of biomolecules have been identified from genus Chaetomium as natural antioxidants, including nucleobases, polyketides, terpenoids, flavonoids, coumarins, xanthones, semiquinones, peptides, and phenolic acids. Other compounds belonging to diverse structural types of chaetoglobosins, epipolythiodioxopiperazines, azaphilones have been recorded. The majority of these Chaetomium’s metabolites are characterized by antibiotic, anticancer, cytotoxic, antimalarial, enzyme inhibitory, and other medical and pharmaceutical activities. In this review we will focus on the chemistry of some important secondary metabolites produced by the genus Cheatomium and their biological uses.

Research topics

  • Radioactive element chemistry and processing

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.21608/rpbs.2024.273362.1273

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.